Advances in Mechanisms Underlying the Comorbidity of Depression and Cardiovascular Disease

doi:10.12114/j.issn.1007-9572.2021.00.430

Abstract

Abstract: There are bidirectional associations between depression and cardiovascular disease （CVD）.In other words，people with depression are more likely to develop CVD than the general population and vice versa.And depression is an independent risk factor for prognosis in patients with CVD.This review summarizes epidemiological evidence on the relationship between depression and CVD，as well as the potential mechanisms of comorbidity of the two，including the influences of unhealthy lifestyle，inflammation，hypothalamic-pituitary-adrenal axis dysfunction and autonomic dysfunction.The discovery of these mechanisms may have important implications for the prevention and treatment of coexistence of depression and CVD，and may suggest that early screening and management of depression in CVD patients are very important and achievable goals.However，more studies are needed to determine the optimal management option for patients with depression and CVD.

Key words: Depressive Disorder, Cardiovascular disease, Life style, Inflammation, Hypothalamic-pituitary-adrenal axis, Heart rate variability

摘要： 抑郁症与心血管疾病之间存在着双向关联，即抑郁症患者比健康个体更易罹患心血管疾病，反之亦然，且抑郁症还是预测心血管疾病患者预后的独立危险因素。本文总结了抑郁症与心血管疾病之间关系的流行病学证据，以及二者共病的潜在发生机制，包括生活方式、炎症、下丘脑-垂体-肾上腺轴及自主神经功能障碍等，这些机制的发现可能对预防及治疗抑郁症与心血管疾病共病有着重要意义，同时也提示早期对心血管疾病患者进行抑郁症筛查、管理，是一个十分重要且可以实现的目标。但如何实现还需要大量研究来确定抑郁症与心血管疾病共病患者的最佳管理方案。

关键词: 抑郁症, 心血管疾病, 生活方式, 炎症, 下丘脑-垂体-肾上腺轴, 心率变异性

WANG Mingxin,LI Suxia,SONG Tao. Advances in Mechanisms Underlying the Comorbidity of Depression and Cardiovascular Disease　[J]. Chinese General Practice, 2021, 24(11): 1426-1430. DOI: 10.12114/j.issn.1007-9572.2021.00.430.
王明鑫,李素霞,宋涛. 抑郁症与心血管疾病共病机制的研究进展[J]. 中国全科医学, 2021, 24(11): 1426-1430. DOI: 10.12114/j.issn.1007-9572.2021.00.430.

References

［1］VIRANI S S，ALONSO A，BENJAMIN E J，et al．Heart disease and stroke statistics-2020 update：a report from the American heart association［J］．Circulation，2020，141（9）：e139-596．DOI：10.1161/CIR.0000000000000757.
［2］FRASURE-SMITH N，LESPéRANCE F.Reflections on depression as a cardiac risk factor［J］．Psychosom Med，2005，67（Suppl 1）：S19-25．DOI：10.1097/01.psy.0000162253.07959.db.
［3］THOMBS B D，BASS E B，FORD D E，et al．Prevalence of depression in survivors of acute myocardial infarction［J］．J Gen Intern Med，2006，21（1）：30-38．DOI：10.1111/j.1525-1497.2005.00269.x.
［4］GRIPPO A J，JOHNSON A K.Stress，depression and cardiovascular dysregulation：a review of neurobiological mechanisms and the integration of research from preclinical disease models［J］．Stress，2009，12（1）：1-21．DOI：10.1080/10253890802046281.
［5］CARNEY R M，FREEDLAND K E.Depression and coronary heart disease［J］．Nat Rev Cardiol，2017，14（3）：145-155．DOI：10.1038/nrcardio.2016.181.
［6］GUSTAD L T，LAUGSAND L E，JANSZKY I，et al．Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study［J］．Eur Heart J，2014，35（21）：1394-1403．DOI：10.1093/eurheartj/eht387.
［7］ANDA R，WILLIAMSON D，JONES D，et al．Depressed affect，hopelessness，and the risk of ischemic heart disease in a cohort of US adults［J］．Epidemiology，1993，4（4）：285-294．DOI：10.1097/00001648-199307000-00003.
［8］LAURSEN T M，MUNK-OLSEN T，NORDENTOFT M，et al．Increased mortality among patients admitted with major psychiatric disorders：a register-based study comparing mortality in unipolar depressive disorder，bipolar affective disorder，schizoaffective disorder，and schizophrenia［J］．J Clin Psychiatry，2007，68（6）：899-907．DOI：10.4088/jcp.v68n0612.
［9］OSBY U，BRANDT L，CORREIA N，et al．Excess mortality in bipolar and unipolar disorder in Sweden［J］．Arch Gen Psychiatry，2001，58（9）：844-850．DOI：10.1001/archpsyc.58.9.844.
［10］FRASURE-SMITH N，LESPéRANCE F.Depression and coronary artery disease［J］．Herz，2006，31（Suppl 3）：64-68.
［11］LESMAN-LEEGTE I，VAN VELDHUISEN D J，HILLEGE H L，et al．Depressive symptoms and outcomes in patients with heart failure：data from the COACH study［J］．Eur J Heart Fail，2009，11（12）：1202-1207．DOI：10.1093/eurjhf/hfp155.
［12］FRASURE-SMITH N，LESPéRANCE F，HABRA M，et al．Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure［J］．Circulation，2009，120（2）：134-140，3pfollowing140．DOI：10.1161/CIRCULATIONAHA.109.851675.
［13］FRASURE-SMITH N.Depression following myocardial infarction［J］．JAMA，1993，270（15）：1819．DOI：10.1001/jama.1993.03510150053029.
［14］LICHTMAN J H，FROELICHER E S，BLUMENTHAL J A，et al．
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association［J］．Circulation，2014，129（12）：1350-1369．DOI：10.1161/CIR.0000000000000019.
［15］ KOZELA M，BOBAK M，BESALA A，et al．The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: Prospective results of the HAPIEE study［J］．Eur J Prev Cardiol，2016，23（17）：1839-1847．DOI：10.1177/2047487316649493.
［16］MEIJER A，CONRADI H J，BOS E H，et al．Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events：individual patient data meta-analysis［J］．Br J Psychiatry，2013，203（2）：90-102．DOI：10.1192/bjp.bp.112.111195.
［17］MEIJER A，CONRADI H J，BOS E H，et al．Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research［J］．Gen Hosp Psychiatry，2011，33（3）：203-216．DOI：10.1016/j.genhosppsych.2011.02.007.
［18］ROELOFFS C A，WELLS K B，ZIEDONIS D，et al．Problem substance use among depressed patients in managed primary care［J］．Psychosomatics，2002，43（5）：405-412．DOI：10.1176/appi.psy.43.5.405.
［19］COHEN B E，PANGULURI P，NA B，et al．Psychological risk factors and the metabolic syndrome in patients with coronary heart disease：findings from the Heart and Soul Study［J］．Psychiatry Res，2010，175（1/2）：133-137．DOI：10.1016/j.psychres.2009.02.004.
［20］BLUMENTHAL J A，BABYAK M A，CARNEY R M，et al．Exercise，depression，and mortality after myocardial infarction in the ENRICHD trial［J］．Med Sci Sports Exerc，2004，36（5）：746-755．DOI：10.1249/01.mss.0000125997.63493.13.
［21］DUTTA P，COURTIES G，WEI Y，et al．Myocardial infarction accelerates atherosclerosis［J］．Nature，2012，487（7407）：325-329．DOI：10.1038/nature11260.
［22］HOWREN M B，LAMKIN D M，SULS J.Associations of depression with C-reactive protein，IL-1，and IL-6：a meta-analysis［J］．Psychosom Med，2009，71（2）：171-186．DOI：10.1097/PSY.0b013e3181907c1b.
［23］HAAPAKOSKI R，MATHIEU J，EBMEIER K P，et al．Cumulative meta-analysis of interleukins 6 and 1β，tumour necrosis factor α and C-reactive protein in patients with major depressive disorder［J］．Brain Behav Immun，2015，49：206-215．DOI：10.1016/j.bbi.2015.06.001.
［24］KHANDAKER G M，ZUBER V，REES J M B，et al．Shared mechanisms between coronary heart disease and depression：findings from a large UK general population-based cohort［J］．Mol Psychiatry，2020，25（7）：1477-1486．DOI：10.1038/s41380-019-0395-3.
［25］PIKHART H，HUBACEK J A，KUBINOVA R，et al．Depressive symptoms and levels of C-reactive protein: a population-based study［J］．Soc Psychiatry Psychiatr Epidemiol，2009，44（3）：217-222．DOI：10.1007/s00127-008-0422-1.
［26］ELOVAINIO M，AALTO A M，KIVIM?KI M，et al．Depression and C-reactive protein： population-based Health 2000 Study［J］．Psychosom Med，2009，71（4）：423-430．DOI：10.1097/PSY.0b013e31819e333a.
［27］KLING M A，ALESCI S，CSAKO G，et al．Sustained low-grade pro-inflammatory state in unmedicated，remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A［J］．Biol Psychiatry，2007，62（4）：309-313．DOI：10.1016/j.biopsych.2006.09.033.
［28］MUSSELMAN D L，MILLER A H，PORTER M R，et al．Higher than normal plasma interleukin-6 concentrations in cancer patients with depression：preliminary findings［J］．Am J Psychiatry，2001，158（8）：1252-1257．DOI：10.1176/appi.ajp.158.8.1252.
［29］NORMANN C，BUTTENSCH?N H N.Gene-environment interactions between HPA-axis genes and stressful life events in depression：a systematic review［J］．Acta Neuropsychiatr，2019，31（4）：186-192．DOI：10.1017/neu.2019.16.
［30］PENNINX B W.Depression and cardiovascular disease：Epidemiological evidence on their linking mechanisms［J］．Neurosci Biobehav Rev，2017，74（Pt B）：277-286．DOI：10.1016/j.neubiorev.2016.07.003.
［31］NEMEROFF C B，VALE W W.The neurobiology of depression：inroads to treatment and new drug discovery［J］．J Clin Psychiatry，2005，66（Suppl 7）：5-13.
［32］STETLER C，MILLER G E.Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research［J］．Psychosom Med，2011，73（2）：114-126．DOI：10.1097/PSY.0b013e31820ad12b.
［33］PARIANTE C M.Why are depressed patients inflamed? A reflection on 20 years of research on depression，glucocorticoid resistance and inflammation［J］．Eur Neuropsychopharmacol，2017，27（6）：554-559．DOI：10.1016/j.euroneuro.2017.04.001.
［34］PARIANTE C M，LIGHTMAN S L.The HPA axis in major depression: classical theories and new developments［J］．Trends Neurosci，2008，31（9）：464-468．DOI：10.1016/j.tins.2008.06.006.
［35］PARIANTE C M.The glucocorticoid receptor: part of the solution or part of the problem?［J］．J Psychopharmacol，2006，20（4 suppl）：79-84．DOI：10.1177/1359786806066063.
［36］WALKER B R.Glucocorticoids and cardiovascular disease［J］．Eur J Endocrinol，2007，157（5）：545-559．DOI；10.1530/EJE-07-0455.
［37］THAYER J F，YAMAMOTO S S，BROSSCHOT J F.The relationship of autonomic imbalance，heart rate variability and cardiovascular disease risk factors［J］．Int J Cardiol，2010，141（2）：122-131．DOI：10.1016/j.ijcard.2009.09.543.
［38］VAN DER KOOY K G，VAN HOUT H P，VAN MARWIJK H W，et al．Differences in heart rate variability between depressed and non-depressed elderly［J］．Int J Geriatr Psychiatry，2006，21（2）：147-150．DOI：10.1002/gps.1439.
［39］KEMP A H，QUINTANA D S，FELMINGHAM K L，et al．Depression，comorbid anxiety disorders，and heart rate variability in physically healthy，unmedicated patients: implications for cardiovascular risk［J］．PLoS One，2012，7（2）：e30777．DOI：10.1371/journal.pone.0030777.
［40］KEMP A H，QUINTANA D S，GRAY M A，et al．Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis［J］．Biol Psychiatry，2010，67（11）：1067-1074．DOI：10.1016/j.biopsych.2009.12.012.
［41］LICHT C M，PENNINX B W，DE GEUS E J.To include or not to include？A response to the meta-analysis of heart rate variability and depression［J］．Biol Psychiatry，2010，69（4）：e1．DOI：10.1016/j.biopsych.2010.06.034.
［42］SGOIFO A，CARNEVALI L，ALFONSO M D E L，et al．Autonomic dysfunction and heart rate variability in depression［J］．Stress，2015，18（3）：343-352．DOI：10.3109/10253890.2015.1045868.
［43］KIM J M，STEWART R，LEE Y S，et al．Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronarysyndrome: a randomized clinical trial［J］．JAMA，2018，320（4）：350-358．DOI：10.1001/jama.2018.9422.
［44］ALMEIDA O P，FORD A H，HANKEY G J，et al．Depression，antidepressants and the risk of cardiovascular events and death in older men［J］．Maturitas，2019，128：4-9．DOI：10.1016/j.maturitas.2019.06.009.
［45］ANGERMANN C E，GELBRICH G，ST?RK S，et al．Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression：the MOOD-HF randomized clinical trial［J］．JAMA，2016，315（24）：2683-2693．DOI：10.1001/jama.2016.7635.
［46］CONNOR C M，JIANG W，KUCHIBHATLA M，et al．Safety and efficacy of sertraline for depression in patients with heart failure：results of the SADHART-CHF（Sertraline Against Depression and Heart Disease in Chronic Heart Failure）trial［J］．J Am Coll Cardiol，2010，56（9）：692-699．DOI：10.1016/j.jacc.2010.03.068.
［47］OSTUZZI G，TURRINI G，GASTALDON C，et al．Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis［J］．Int Clin Psychopharmacol，2019，34（2）：65-75．DOI：10.1097/YIC.0000000000000248.
［48］LICHTMAN J H，BIGGER J T Jr，BLUMENTHAL J A，et al．Depression and coronary heart disease：recommendations for screening，referral，and treatment：a science advisory from the American heart association prevention committee of the council on cardiovascular nursing，council on clinical cardiology，council on epidemiology and prevention，and interdisciplinary council on quality of care and outcomes research：endorsed by the American psychiatric association［J］．Circulation，2008，118（17）：1768-1775．DOI：10.1161/CIRCULATIONAHA.108.190769.

[1]	ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472.
[2]	LU Donglei, YANG Fengying, FENG Zhanpeng, CAO Liquan, TAN Sijie. Conccurent Training Can Improve the Physical Health in Diabesity Individuals: a Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3410-3421.
[3]	HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258.
[4]	XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239.
[5]	LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078.
[6]	YANG Handan, QIAO Wen, HE Shu, CHEN Yi, TONG Yunmei. The Impact of Acceptance and Commitment Therapy Combined with Sertraline on Depressive Mood, Suicidal Ideation, and Sleep Quality of Adolescents with Depression [J]. Chinese General Practice, 2025, 28(22): 2813-2818.
[7]	PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293.
[8]	LIU Rong, LI Guoxin, LI Yunze, LIANG Lizhe, LU Fei, DANG Shijing, WU Hongjiang, LIU Xiaoyi. Study on the Correlation and Diagnostic Value of Multiple Inflammatory and Oxidative Stress Indices in Lower Extremity Arteriosclerotic Obliteration [J]. Chinese General Practice, 2025, 28(18): 2234-2240.
[9]	HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284.
[10]	HAN Chao, ZHAN Xiaofei, YAN Qin, YU Xin, TONG Yan, PANG Zhenzhen, XIE Hongxiang. Analysis of the Clinical Application Value of Systemic Inflammatory Index in Assisting the Diagnosis of Subacute Thyroiditis [J]. Chinese General Practice, 2025, 28(18): 2241-2246.
[11]	ZHANG Bingqing, WANG Zhongkai, WU Changyong, SUN Huang, LI Ruijie, LIU Wenjie, LUO Yihua, ZHENG Lihui, PENG Yunzhu. Changes and Trend Prediction in the Global Burden of Congenital Heart Defects, 1990-2021 [J]. Chinese General Practice, 2025, 28(18): 2253-2261.
[12]	AN Qinyu, WANG Yiying, ZHANG Xiaodan, ZHANG Tianlin, ZHAN Qingqing, ZHANG Fuyan, LIU Tao, WU Yanli. Prospective Cohort Study of the Impact of Socioeconomic Status and Healthy Lifestyle on Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(16): 2017-2024.
[13]	CHEN Yijing, XU Qi, LIU Zhongdian, QIN Lingqiao, CHEN Shuping, TANG Weiting, ZHONG Qiuan. The Regulatory Role of Hexosamine Biosynthesis Pathway in Vascular Endothelial Inflammation [J]. Chinese General Practice, 2025, 28(15): 1871-1877.
[14]	NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei. Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks [J]. Chinese General Practice, 2025, 28(15): 1847-1854.
[15]	ZHANG Qi, HE Shen, LI Hua. Interpretation of Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement 2022 [J]. Chinese General Practice, 2025, 28(15): 1823-1830.